1. Search Result
Search Result
Results for "

galactosyltransferase

" in MedChemExpress (MCE) Product Catalog:

22

Inhibitors & Agonists

6

Biochemical Assay Reagents

1

Peptides

1

Natural
Products

7

Recombinant Proteins

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-E70289

    Bovin B4GALT1 (Y289L)

    Endogenous Metabolite Others
    Bovin beta-1,4-galactosyltransferase 1 (Y289L) (Bovin B4GALT1 (Y289L)) is a mutated form of bovine-derived galactosyltransferase with a mutation at the Y289L genetic site. Bovin beta-1,4-galactosyltransferase 1 can label O-GlcNAcylated proteins with an N-azidoacetylgalactosamine (GalNAz) group. This labeling method allows for the specific, unbiased, and global labeling of O-GlcNAcylated proteins. After labeling, the appended azide group can react with a wide variety of alkyne-modified chemical probes, facilitating multiple downstream analyses .
    Bovin beta-1,4-galactosyltransferase 1 (Y289L)
  • HY-E70285

    B4GALT1 (Y285L)

    Endogenous Metabolite Metabolic Disease
    beta-1,4-Galactosyltransferase 1 (Y285L) can enzymatic synthesis of the LacdiNAc motif. beta-1,4-Galactosyltransferase 1 (Y285L) can transfer of GalNAc from UDP-GalNAc .
    beta-1,4-Galactosyltransferase 1 (Y285L)
  • HY-131703
    UGT8-IN-1
    1 Publications Verification

    UGT Metabolic Disease
    UGT8-IN-1 is a brain penetrable and orally active inhibitor of ceramide galactosyltransferase enzyme (UGT8). UGT8-IN-1 can be used in the study for lysosomal storage disorders .
    UGT8-IN-1
  • HY-NP009

    Bacterial Infection Neurological Disease
    α-Lactalbumin is a globular whey protein that exists in milk. α-Lactalbumin binds Ca 2+, Mg 2+, Mn 2+, Na +, K + and Zn 2+ ions; among these, Ca 2+ binding enhances protein stability, while Zn 2+ binding reduces stability and induces aggregation. α-Lactalbumin forms amyloid fibrils, amorphous aggregates, nanoparticles and nanotubes depending on external conditions. α-Lactalbumin exhibits bactericidal and antiviral activities. α-Lactalbumin has anxiolytic and antidepressant activities, and its effects are enhanced under stress conditions .
    α-Lactalbumin
  • HY-150524

    Endogenous Metabolite P2Y Receptor Metabolic Disease
    UDP-Galactose is a monosaccharide and a key glycosyl donor molecule in cells that participates in nucleotide sugar metabolism. UDP-Galactose is the natural agonist of the P2Y14 receptor coupled to Gi proteins in the immune system (IC50 = 0.67 μM, hP2Y14). UDP-Galactose can be used to study cell signal transduction and substance metabolism .
    UDP-Galactose
  • HY-E70046

    Endogenous Metabolite Metabolic Disease
    beta-1,4-Galactosyltransferase (LgtB) (EC 2.4.1.90) (B4GALT1 (LgtB)) is often used in biochemical studies. beta-1,4-Galactosyltransferase (LgtB) catalyzes the reaction involving UDP-galactose and N-acetylglucosamine for the production of galactose beta-1,4-N-acetylglucosamine .
    β-1,4-Galactosyltransferase, neisseria meningitides
  • HY-W718137

    Biochemical Assay Reagents Others
    6-Azido-6-deoxy-D-galactose, 95% can be used as a substrate in enzymology to study the activity and specificity of galactosyltransferases and other glycosylation enzymes.
    6-Azido-6-deoxy-D-galactose, 95%
  • HY-E70047

    A4GALT

    Glycosyltransferase Metabolic Disease
    alpha-1,4-Galactosyltransferase (LgtC) (A4GALT) is a glycosphingolipid-specific glycosyltransferase. alpha-1,4-Galactosyltransferase (LgtC) transfers a galactose to the alpha-1,4 position of lactosylceramide to form globotriaosylceramide. alpha-1,4-Galactosyltransferase (LgtC) can be used for the synthesis of P1 blood group antigens .
    alpha-1,4-Galactosyltransferase (LgtC)
  • HY-E70138

    EC:2.4.1.133; B4GALT7

    Glycosyltransferase Others
    β-1,4-Galactosyltransferase 7 has exclusive specificity for the donor substrate UDP-galactose and all transfer galactose in a β-1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. .
    β-1,4-Galactosyltransferase 7
  • HY-E70052

    GGTA1

    Endogenous Metabolite Metabolic Disease
    alpha-1,3-Galactosyltransferase (a1,3GalT) (GGTA1) catalyzes the generation of the α-gal glycan via the transfer of a galactose (Gal) in α1-3 linkage, from a uridyl-diphosphate (UDP) donor onto the N-acetyllactosamine (Galβ1,4GlcNAc-R) of glycoproteins. alpha-1,3-Galactosyltransferase (a1,3GalT) is responsible for the synthesis of the α-galactose (α-Gal) epitope found in most mammalian species .
    alpha-1,3-Galactosyltransferase (a1,3GalT)
  • HY-E70053

    alpha 1,3GT

    Endogenous Metabolite Metabolic Disease
    alpha-1,3-Galactosyltransferase (GTB) (alpha 1,3GT) catalyzes the synthesis of the xenoantigen or α-galactose (α-Gal) epitope. alpha-1,3-Galactosyltransferase (GTB) transfers galactose from UDP-Gal to type 1 or type 2, αFuc1→2βGal-R (H)-terminating acceptors .
    alpha-1,3-Galactosyltransferase (GTB)
  • HY-E70060

    EB4GALT1 (LgtE)

    Others Others
    beta-1,4-Galactosyltransferase (LgtE) (EB4GALT1 (LgtE)) catalyzes the reaction involving UDP-galactose and N-acetylglucosamine for the production of galactose beta-1,4-N-acetylglucosamine .
    beta-1,4-Galactosyltransferase (LgtE)
  • HY-B1610K

    Biochemical Assay Reagents Others
    Sodium Citrate Buffer, 0.5M, pH 5.5 is a metal chelator and buffering agent. Sodium Citrate Buffer, 0.5M, pH 5.5 requires oxygen to participate in the oxidation process to reduce pink defects in cooked ground turkey, and it does not function via heme iron chelation or iron complex interaction. When mixed with 50% (by vol.) 1,3-dimethylimidazolium methyl sulfate, Sodium Citrate Buffer, 0.5M, pH 5.5 can serve as an aqueous buffering medium to maintain the catalytic efficiency of the hyperthermophilic β-glycosidase CelB for lactose hydrolysis at 80°C, while also acting as a reaction medium for CelB-catalyzed lactose hydrolysis and galactosyltransferase assays .
    Sodium Citrate Buffer, 0.5M, pH 5.5
  • HY-E70054

    Others Others
    beta-1,3-Galactosyltransferase (WbgO) (CgtB) acts on N-glycan substrates. beta-1,3-Galactosyltransferase (WbgO) catalyzes the formation of type 1 chains on oligosaccharide, glycopeptide, and glycoprotein substrates, including itself .
    beta-1,3-Galactosyltransferase (WbgO)
  • HY-E70050

    Endogenous Metabolite Others
    beta-1,3-Galactosyltransferase (CgtB) (GM1-synthase) is an enzyme that required for sialylated lipooligosaccharide (LOS SIAL) production, is often used in biochemical studies. beta-1,3-Galactosyltransferase (CgtB) catalyzes the addition of a galactose molecule, which is required for GM1-like LOS SIAL structure production .
    beta-1,3-Galactosyltransferase (CgtB)
  • HY-E70046A

    Bovine B4GALT1

    Glycosyltransferase Others
    Bovine beta-1,4-Galactosyltransferase (Bovine B4GALT1) is a one member of the glycosyltransferase family of enzymes. Bovine beta-1,4-Galactosyltransferase transfers galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) to produce N-acetyllactosamine with a β-1,4-glycosidic linkage .
    Bovine beta-1,4-Galactosyltransferase
  • HY-E70191

    EC:2.4.1.22; B4GALT2

    Glycosyltransferase Others
    β-1,4-Galactosyltransferase 2 catal exclusive specificity for the donor substrate UDP-galactose and all transfer galactosein a beta1,4 linkage .
    β-1,4-Galactosyltransferase 2
  • HY-137798

    Fluorescent Dye Others
    Chromozym PL is a chromogenic substrate for plasmin, and the enzymatic reaction can be carried out in 0.1mL Tris-HCl buffer (50 mM, pH 7.8). 100 μM Chromozym PL was dissolved and prepared. After adding the hydrolase, the generation of p-nitroaniline (pNA) at 405 nm was continuously observed, and the hydrolysis products were calculated .
    Chromozym PL
  • HY-149125

    Ceramide trihexosides (porcine)

    HIV Infection
    Globotriaosylceramide porcine RBC is a trihexosylceramide (Gb3) in porcine erythrocytes. Globotriaosylceramide porcine RBC is a natural resistance factor against HIV-1 infection. The synthetase α-galactosyltransferase (A4GALT) of Globotriaosylceramide porcine RBC is associated with HIV-1 resistance.
    Globotriaosylceramide (porcine RBC)
  • HY-E70139

    EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II

    Glucosylceramide Synthase (GCS) Others
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 ( EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II) is a glycosyltransferase .
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2
  • HY-E71320

    Biochemical Assay Reagents Others
    Terminal N-acetyl-β-D-glucosaminyl residues in polysaccharides, glycoproteins and glycopeptides can act as acceptor. High activity is shown towards such residues in branched-chain polysaccharides when these are linked by β-1,6-links to galactose residues; lower activity towards residues linked to galactose by β-1,3-links. A component of EC 2.4.1.22 (lactose synthase) .
    β-N-Acetylglucosaminylglycopeptide β-1,4-galactosyltransferase
  • HY-180371

    Drug Derivative Cancer
    NF-115 is a glycolipid inhibitor. NF-115 inhibits proliferation of glioma cancer cells and exhibits potent antimitotic activity in human astroblastoma cells. NF-115 can be used for research on glioma .
    NF-115

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: